Hemanext is a medical technology company offering a blood processing, storage, and transfusion solution.
Hemanext has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.
Hemanext's investors include Vitalant.
Hemanext is headquartered in Lexington, United States.
Hemanext is a medical technology company offering a blood processing, storage, and transfusion solution.
Hemanext is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hemanext — Funding & Investors." VCBacked, August 4, 2025, https://www.vcbacked.co/company/hemanext. Accessed July 23, 2026.
VCBacked. (2025). Hemanext — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/hemanext
{{cite web |title=Hemanext — Funding & Investors |url=https://www.vcbacked.co/company/hemanext |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated